Incyte Corporation

World Rank (Jan-05-2024)

1,185

Market Cap (Jan-05-2024)

14.923 Billion USD

World Rank (Jul-30-2023)

1,265

Market Cap (Jul-30-2023)

14.075 Billion USD

World Rank (Jan-07-2022)

1,253

Market Cap (Jan-07-2022)

16.167 Billion USD

World Rank (Jan-01-2021)

950

Market Cap (Jan-01-2021)

19.048 Billion USD

Company Rank in Country in 2023

Rank in USA in July-2023 is 494

Headquarters Country

USA

Nasdaq / NYSE Code

INCY

Market Cap (Mar-08-2026)

19.09

CEO

Herve Hoppenot

Employee Count

2,324

Employee Count as of Date

As on 2022

Headquarters City/State

Delaware

World Region

Americas

World Subregion

Northern America

Annual Revenue in USD

3,394 Million USD

Annual Operating Income in USD

591 Million USD

Annual Net Income in USD

340 Million USD

Annual Results for Period Ending

Dec-2022 ending year

Total Assets in USD

5,840 Million USD

Total Liabilities in USD

1,470 Million USD

Total Equity in USD

4,370 Million USD

Balance Sheet for Period Ending

Dec-2022 ending year

Business Sector

Company Website

Incyte Corporation - Pharmaceutical Company

Wikipedia

Yahoo

Yahoo @ Nasdaq

Facebook

Company Profile

Incyte Corporation is a Bio-Pharmaceutical company with headquarters is in Delaware, USA.

As on 2021, Incyte Corporation has 2,094 employees, 989 are in research and development, 187 in medical affairs, 638 in sales and marketing and 280 in operations support, finance and administrative positions.

As on 2022, Incyte Corporation has 2,324 employees.

Incyte Corporation annual revenue generated for period ending Dec-2022 was 3,394 million USD.

Incyte Corporation annual net income generated for period ending Dec-2022 was 340 million USD.

Annual Results Summary

INCYTE CORPORATION - Annual Results Summary - in Million USD

Year Ending:	Total Revenue	Gross Profit	Operating Income	Net Income
Dec-2023	3,695	3,440	649	597
Dec-2022	3,394	3,187	591	340
Dec-2021	2,986	2,856	585	948
Dec-2020	2,667	2,535	-264	-296
Dec-2019	2,159	2,045	402	447
Dec-2018	1,882	1,788	129	109
Dec-2017	1,536	1,457	-243	-313

Balance Sheet Summary

INCYTE CORPORATION - Balance Sheet Summary - in Million USD

Year Ending:	Total Assets	Total Liabilities	Total Equity
Dec-2022	5,840	1,470	4,370
Dec-2021	4,933	1,163	3,770
Dec-2020	3,561	949	2,611
Dec-2019	3,426	828	2,598
Dec-2018	2,645	720	1,926
Dec-2017	2,301	672	1,630